Alps Advisors Inc Hutchmed (China) LTD Transaction History

Alps Advisors Inc

  • $14.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019
SELL
$23.09 - $37.69 $5.43 Million - $8.86 Million
-235,130 Closed
0 $0
Q3 2018

Oct 25, 2018
BUY
$26.55 - $34.38 $1.15 Million - $1.49 Million
43,197 Added 22.51%
235,130 $7.57 Million
Q2 2018

Aug 02, 2018
BUY
$27.79 - $34.49 $5.33 Million - $6.62 Million
191,933 New
191,933 $5.79 Million

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email